ibd

Putative biomarkers of vedolizumab resistance and underlying inflammatory pathways involved in IBD
Christoffer Soendergaard, Jakob Benedict Seidelin, Casper Steenholdt, Ole Haagen Nielsen

BMJ Open Gastroenterology May 2018, 5 (1) e000208; DOI: 10.1136/bmjgast-2018-000208
Results from a retrospective analysis of colonoscopies for Inflammatory bowel disease and colorectal cancer in a Lebanese tertiary care centre
Toufic Saber, Khalil Bedran, Fatima Ghandour, Mansour El Khoury, Roula Bou Khalil, Said Farhat

BMJ Open Gastroenterology Sep 2017, 4 (1) e000167; DOI: 10.1136/bmjgast-2017-000167
Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)
Juliette Sheridan, Carol Ann Coe, Peter Doran, Laurence Egan, Garret Cullen, David Kevans, Jan Leyden, Marie Galligan, Aoibhlinn O’Toole, Jane McCarthy, Glen Doherty

BMJ Open Gastroenterology Jan 2018, 5 (1) e000174; DOI: 10.1136/bmjgast-2017-000174

Main menu